Cirrhosis
Portal vein thrombosis
Budd-Chiari
Porto-sinusoidal vascular disease
Final Jeopardy
100

When do you need to take the INR into account before procedures in patients with cirrhosis?

When patients are on vitamin K antagonists

100

Why is early anticoagulation recommended for PVT?

reduces the risk of intestinal ischemia, increases the probability of portal vein recanalization

100

What is the first line imaging modality for BCS?

Doppler ultrasound

100

How do you make the diagnosis of PSVD?

Liver biopsy (with reticulin stain to rule out cirrhosis)

100

When and why would a liver biopsy be indicated in patients with recent or chronic PVT/portal cavernoma without known cirrhosis?

If blood tests, imaging or an elevated LSM suggests cirrhosis because if the liver biopsy shows cirrhosis, then the patient will need screening for HCC

200

In patients with cirrhosis and PVT, why is routine anticoagulation after TIPS generally not recommended?

Because it does not improve recanalization rates, and unnecessary anticoagulation may increase bleeding risk without proven benefit.

200

True or false: MASLD is an independent risk factor for PVT

True

200

Name two of the most common causes of PVT/primary BCS in the absence of cirrhosis

Abdominal cancer (30%), Inflammation/infection (20-20%), myeloproliferative disorders, inherited thrombophilia. (Other less common: antiphospholipid antibody, paroxysmal nocturnal hemoglobinema, Behcet, oral contraceptives, pregnancy)

200

Name one of the diseases that now falls under the name portosinusoidal vascular disease

Nodular regenerative hyperplasia, hepatoportal sclerosis, incomplete septal cirrhosis,or obliterative portal venopathy in the West. Non-cirrhotic portal fibrosis in India, idiopathic
portal hypertension in Japan 

300

Name two potential clinical benefits of anticoagulation in patients with Child-Pugh B or C cirrhosis without PVT

Reduction in morbidity

Reduction in mortality

300

What other Medicine sub-specialty can help in the workup for PVT risk factors in patients without cirrhosis?

Hematology (myeloproliferative disorders)

300

Should patients with BCS be surveilled for HCC?

yes, every 6 months 

300

What is the recommended surveillance interval for detecting portal vein thrombosis in patients with porto-sinusoidal vascular disease?

Every 6 months

400

In patients with cirrhosis and PVT, name two complications that may prompt consideration of TIPS rather than anticoagulation alone.

Variceal bleeding

Recurrent ascites

400

Name two anticoagulants that can be used for PVT.

LMWH: more effective than warfarin

Vitamin K antagonists: once daily but require monitoring

DOACs: insufficient data to compare with LMWH or VKA; contraindicated in Child-Pugh C

400

In non-fulminant BCS, what are the initial steps in management

Anticoagulate and treat underlying condition

400

True or false: Routine surveillance for hepatocellular carcinoma (HCC) is recommended in patients with PSVD.

False

500

What is the risk factor for PVT that needs to be ruled out in patients with cirrhosis?

HCC

500

What is the treatment for patients with chronic PVT/portal cavernoma without cirrhosis and refractory complications of portal hypertension?

TIPS± endovascular portal vein recanalization (the latter requires a patent intrahepatic portal branch and depends on the extent of the portal cavernoma).

500

What is the approach for BCS with acute liver failure

  • TIPS or DIPS and list for transplant
500

True or false: There is sufficient evidence to recommend routine anticoagulation in PSVD to prevent portal vein thrombosis

False